Walgreens Boots Alliance (WBA) Expected to Announce Quarterly Earnings on Thursday

Walgreens Boots Alliance (NASDAQ:WBA) is expected to post its quarterly earnings results before the market opens on Thursday, March 27th. Analysts expect Walgreens Boots Alliance to post earnings of $0.53 per share and revenue of $37.90 billion for the quarter. Walgreens Boots Alliance has set its FY 2025 guidance at 1.400-1.800 EPS and its FY25 guidance at $1.40-$1.80 EPS.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter in the previous year, the company earned $0.66 earnings per share. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. On average, analysts expect Walgreens Boots Alliance to post $2 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Walgreens Boots Alliance Trading Up 0.5 %

Shares of NASDAQ WBA opened at $11.15 on Tuesday. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $9.64 billion, a PE ratio of -1.09, a PEG ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance has a twelve month low of $8.08 and a twelve month high of $22.05. The stock has a fifty day simple moving average of $10.94 and a 200-day simple moving average of $9.85.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on WBA. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and lowered their target price for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Evercore ISI increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Bank of America boosted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Finally, StockNews.com started coverage on shares of Walgreens Boots Alliance in a report on Tuesday, March 18th. They set a “hold” rating for the company. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.